STEMI patients - The more you bleed, the more you die: A comparison between classifications

Clinical Cardiology

Volumn 34, Issue 2, 2011, Pages 90-96

  Valente, Serafina ^a   Lazzeri, Chiara ^a   Chiostri, Marco ^a   Osmanagaj, Lusinda ^a   Giglioli, Cristina ^a   Gensini, Gian Franco ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

ACUTE CATHETERIZATION AND URGENT INTERVENTION TRIAGE STRATEGY CLASSIFICATION; ACUTE CORONARY SYNDROME; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; DISEASE CLASSIFICATION; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; REGISTER; REVASCULARIZATION; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOLYSIS IN MYOCARDIAL INFARCTION CLASSIFICATION;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; ITALY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 79751480465     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20842     Document Type: Article

References (24)

1. Willis P, Voeltz MD., Anemia, hemorrhage, and transfusion in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. Am J Cardiol. 2009; 104 (5 suppl): 34C-38C.
2. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993; 329: 673-682.
3. Manoukian SV., Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes and ST-segment elevation myocardial infarction. Am J Cardiol. 2009; 104 5 suppl: 9C-15C.
4. Boersma E, Akkerhuis KM, Theroux P, et al. Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. Circulation. 1999; 100: 2045-2048. (Pubitemid 29532053)
5. Stone GW, Witzenbichler B, Guagliumi G, et al. HORIZONS-AMI Trial Investigators. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008; 358: 2218-2230. (Pubitemid 351724451)
6. Stone GW, White HD, Ohman EM, et al. Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial Investigators. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. Lancet. 2007; 369: 907-919. (Pubitemid 46400858)
7. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis In Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 1987; 76: 142-154. (Pubitemid 17093202)
8. Feit F, Voeltz MD, Attubato MJ, et al. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol. 2007; 100: 1364-1369. (Pubitemid 47576015)
9. Valente S, Lazzeri C, Chiostri M, et al. NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI with extension of STEMI and inflammatory markers. Int J Cardiol. 2009; 132: 84-89.
10. Valente S, Lazzeri C, Salvadori C, et al. Effectiveness and safety of routine primary angioplasty in patients aged > or = 85 years with acute myocardial infarction. Circ J. 2008; 72: 67-70. (Pubitemid 351413329)
11. Valente S, Lazzeri C, Chiostri M, et al. Time of onset and outcome of cardiogenic shock in acute coronary syndromes. J Cardiovasc Med (Hagerstown). 2008; 9: 1235-1240.
12. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined [published correction appears in J Am Coll Cardiol. 2001;37:973]. J Am Coll Cardiol. 2000; 36: 959-969.
13. Boden WE, O'Rourke RA, Teo KK, et al. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356: 1503-1516. (Pubitemid 46588415)
14. National Kidney Foundation. K/DOQI: clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39 (2 suppl 1): S1-S266.
15. Rao SV, O'Grady K, Pieper KS, et al. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol. 2006; 47: 809-816. (Pubitemid 43243106)
16. Rao SV, Eikelboom JA, Granger CB, et al. Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007; 28: 1193-1204. (Pubitemid 47343833)
17. Bassand JP., Bleeding and transfusion in acute coronary syndromes: a shift in the paradigm. Heart. 2008; 94: 661-666.
18. Nikolsky E, Mehran R, Dangs G, et al. Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. Eur Heart J. 2007; 28: 1936-1945. (Pubitemid 47579535)
19. Mehran R, Pocock SJ, Nikolsky E, et al. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010; 55: 2556-2566.
20. Manoukian SV, Voeltz MD, Eikelboom J., Bleeding complications in acute coronary syndromes and percutaneous coronary intervention: predictors, prognostic significance and paradigms for reducing risk. Clin Cardiol. 2007; 30 (10 suppl 2): II24-II34. (Pubitemid 47587496)
21. Bassand JP., Acute coronary syndromes and percutaneous coronary interventions. Hamostaseologie. 2009; 29 381-387.
22. Manoukian SV, Feit F, Mehran R, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial. J Am Coll Cardiol. 2007; 49: 1362-1368. (Pubitemid 46476844)
23. Moscucci M, Fox KA, Cannon CP, et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2003; 24: 1815-1823. (Pubitemid 37280247)
24. Siudak Z, Zawislak B, Dziewierz A, et al. Transradial approach in patients with ST-elevation myocardial infarction treated with abciximab results in fewer bleeding complications: data from EUROTRANSFER registry. Coron Artery Dis. 2010; 21: 292-297.